# Safety Escalating Repeat IV, in Stroke Patients

> **NCT00833989** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 42 (actual)

## Conditions studied

- Ischaemic Attack, Transient

## Interventions

- **DRUG:** GSK249320
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT00833989
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-08
- **Primary completion:** 2011-01-31
- **Final completion:** 2011-01-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833989, "Safety Escalating Repeat IV, in Stroke Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00833989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*